Division of Surgery and Interventional Science, University College London, Royal Free Hospital Campus, London, UK.
Department of Plastic Surgery, Royal Free Hospital, London, UK.
Ann Biomed Eng. 2020 Jan;48(1):9-25. doi: 10.1007/s10439-019-02373-3. Epub 2019 Oct 1.
Current techniques for breast reconstruction include an autologous-tissue flap or an implant-based procedure, although both can impose further morbidity. This systematic review aims to explore the existing literature on breast reconstruction using a tissue engineering approach; conducted with the databases Medline and Embase. A total of 28 articles were included, mainly comprising of level-5 evidence with in vitro and animal studies focusing on utilizing scaffolds to support the migration and growth of new tissue; scaffolds can be either biological or synthetic. Biological scaffolds were composed of collagen or a decellularized tissue matrix scaffold. Synthetic scaffolds were primarily composed of polymers with customisable designs, adjusting the internal morphology and pore size. Implanting cells, including adipose-derived stem cells, with combined use of basic fibroblast growth factor has been studied in an attempt to enhance tissue regeneration. Lately, a level-4 evidence human case series was reported; successfully regenerating 210 mL of tissue using an arterio-venous pedicled fat flap within a tissue engineering chamber implanted on the chest wall. Further research is required to evaluate whether the use of cells and other growth factors could adjust the composition of regenerated tissue and improve vascularity; the latter a major limiting factor for creating larger volumes of tissue.
目前的乳房重建技术包括自体组织皮瓣或基于植入物的手术,但两者都可能带来进一步的发病率。本系统评价旨在探索使用组织工程方法进行乳房重建的现有文献;使用 Medline 和 Embase 数据库进行检索。共纳入 28 篇文章,主要为 5 级证据,包括体外和动物研究,重点是利用支架来支持新组织的迁移和生长;支架可以是生物的或合成的。生物支架由胶原蛋白或脱细胞组织基质支架组成。合成支架主要由聚合物组成,具有可定制的设计,可以调整内部形态和孔径。已经研究了植入细胞,包括脂肪来源干细胞,并结合使用碱性成纤维细胞生长因子,以试图增强组织再生。最近,报道了一项 4 级证据的人体病例系列研究;在胸壁植入的组织工程室内成功再生了 210 毫升组织,使用的是带蒂动静脉脂肪瓣。需要进一步研究以评估细胞和其他生长因子的使用是否可以调整再生组织的组成并改善血管生成;后者是创建更大体积组织的主要限制因素。